Piccolo genotype modulates neural correlates of emotion processing but not executive functioning

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Major depressive disorder (MDD) involves emotional and cognitive symptoms linked to brain activity and neurotransmission.
• A genome-wide association study identified a piccolo (PCLO) gene polymorphism (rs2522833) as an MDD risk factor, yet its functional impact remained unclear.

Purpose of the Study:

• To investigate the effect of the PCLO risk allele on emotion processing and executive function.
• To examine the neural substrates associated with the PCLO risk allele using functional magnetic resonance imaging (fMRI).

Main Methods:

• fMRI was employed to compare PCLO risk allele carriers and non-carriers.
• Participants (159 MDD patients and healthy controls) performed emotional face processing and visuospatial planning tasks.
• Analysis focused on amygdala and prefrontal cortex activity.

Main Results:

• PCLO risk allele carriers showed increased left amygdala activity when processing angry and sad faces, irrespective of MDD status.
• Fearful face processing elicited heightened amygdala activation in MDD patients with the PCLO risk allele.
• No significant genotype effects were observed for executive function tasks (performance or brain activity).

Conclusions:

• The PCLO risk allele is specifically associated with altered emotion processing, particularly amygdala function, in the context of MDD.
• This genetic variant may contribute to depression susceptibility through its influence on processing fearful stimuli.
• Findings illuminate potential neurobiological mechanisms linking genotype to MDD vulnerability.